The ECASS III results and the tPA paradox

International Journal of Stroke

Volumn 4, Issue 1, 2009, Pages 17-18

  Davis, Stephen ^a   Donnan, Geoffrey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG UTILIZATION; EARLY INTERVENTION; HEALTH CARE DELIVERY; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; STROKE; TIME; TISSUE PLASMINOGEN ACTIVATOR;

EID: 60549095952     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00248.x     Document Type: Note

References (13)

1. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-29.
2. NINDS rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-7.
3. Saver JL: Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: Novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004; 61: 1066-70.
4. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-74.
5. Darby DG, Barber PA, Gerraty RP et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999; 30: 2043-52.
6. Barber PA, Darby DG, Desmond PM et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998; 51: 418-26.
7. Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309.
8. Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-17.
9. Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase 3-4.5h after acute ischaemic stroke (SITS-ISTR): An observational study. Lancet 2008; 372: 1303-9.
10. Whiteley W, Lindley R, Wardlaw J, Sandercock P: Third international stroke trial. Int J Stroke 2006; 1: 172-6.
11. Hoffman JR, CooWer RJ: Stroke thrombolysis: we need new data, not more reviews. Lancet Neurol 2005; 4: 204-5.
12. Weir L, Cadilhac DA: Managing a stroke unit: an example from Australia with an emphasis on nursing roles. Int J Stroke 2007; 2: 201-7.
13. Saver JL: Time is brain - quantified. Stroke 2006; 37: 263-6.